DNA Capital led a ~USD60m round in Memed, a Brazilian provider of digital drug prescriptions, to expand its services from prescriptions to drug fulfillment. DNA Capital invested through a vehicle structured…
-
-
DNA Capital led a US$4.5m Series B in Memed, a Brazilian provider of digital drug prescriptions, and followed on in Feegow, a Brazilian medical clinic software provider. (Valor Econômico) Enquanto…
-
Redpoint eventures and DNA Capital, the corporate venture arm of DASA, led a US$4.5m investment in Memed, a Brazilian digital prescription platform. Qualcomm Ventures, monashees and Redpoint invested previously. (Press…